TeamTRACS Pilot (CTSI)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05370157 |
Recruitment Status :
Completed
First Posted : May 11, 2022
Last Update Posted : May 6, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Teamwork Implementation | Behavioral: TeamTRACS | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 162 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Improving Teamwork in Rural Child Advocacy Centers: A Hybrid-Effectiveness Implementation Trial of TeamTRACS |
Actual Study Start Date : | June 8, 2022 |
Actual Primary Completion Date : | March 22, 2023 |
Actual Study Completion Date : | March 22, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: TeamTRACS (Team Training in Roles, Awareness, Communication, and Support)
CACs randomized to the intervention condition (n = 4) will participate in TeamTRACS. CACs will receive an implementation guide to assist in preparing for and maximizing the impact of training.
|
Behavioral: TeamTRACS
TeamTRACS is a team training intervention adapted from TeamSTEPPS (Team Strategies and Tools to Enhance Performance and Patient Safety), a widely used evidence-based team training developed by the Agency for Healthcare Research and Quality. TeamTRACS targets knowledge, skills, and attitudes related to team member roles, shared awareness, communication, mutual support, and goal-setting. TeamTRACS is structured, easy to use, flexible in length and intensity, and requires few resources. It incorporates didactic instruction, discussion, and interactive activities and can be delivered virtually or in-person. |
No Intervention: Waitlist Comparison
CACs randomized to the waitlist comparison (n = 2) will participate in TeamTRACS approximately 4 months after CACs in the intervention condition.
|
- Change in teamwork knowledge from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]Survey questions assessing knowledge taught in TeamTRACS will be assessed with multiple choice questions. The percent of correct answers (range 0-100%) will be calculated.
- Change in teamwork skill use from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]Frequency of teamwork skill use will be assessed with survey items rated on a 5-point Likert scale. Scores will be averaged; higher scores indicate more frequent skill use.
- Acceptability of self-guided implementation [ Time Frame: Baseline ]Perceived acceptability of the self-guided implementation process will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Acceptability of self-guided implementation [ Time Frame: Month 4 ]Perceived acceptability of the self-guided implementation process will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Acceptability of self-guided implementation [ Time Frame: Month 8 ]Perceived acceptability of the self-guided implementation process will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Appropriateness of self-guided implementation [ Time Frame: Baseline ]Perceived appropriateness of the self-guided implementation process will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Appropriateness of self-guided implementation [ Time Frame: Month 4 ]Perceived appropriateness of the self-guided implementation process will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Appropriateness of self-guided implementation [ Time Frame: Month 8 ]Perceived appropriateness of the self-guided implementation process will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Feasibility of self-guided implementation [ Time Frame: Baseline ]Perceived feasibility of the self-guided implementation process will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Feasibility of self-guided implementation [ Time Frame: Month 4 ]Perceived feasibility of the self-guided implementation process will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Feasibility of self-guided implementation [ Time Frame: Month 8 ]Perceived feasibility of the self-guided implementation process will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.
- Change in team functioning from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]Affective, behavioral, and cognitive processes and states will be assessed with survey items rated on Likert scales. Scores will be averaged; higher scores indicate more adaptive team functioning.
- Change in team performance from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]The overall quality of work done by the team will be assessed with with Edmondson's (1999) Team Performance scale of 5 items rated on a 7-point Likert scale. Scores will be averaged; higher scores indicate better performance.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Individuals at least 18 years of age who are members of the multidisciplinary team at the participating CACs.
Exclusion Criteria:
- Under 18 years old

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05370157
United States, Pennsylvania | |
University of Pittsburgh | |
Pittsburgh, Pennsylvania, United States, 15213 |
Principal Investigator: | Elizabeth A McGuier, PhD | University of Pittsburgh |
Responsible Party: | Elizabeth McGuier, Assistant Professor of Psychiatry, University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT05370157 |
Other Study ID Numbers: |
STUDY21110090 UL1TR001857 ( U.S. NIH Grant/Contract ) |
First Posted: | May 11, 2022 Key Record Dates |
Last Update Posted: | May 6, 2023 |
Last Verified: | May 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Deidentified data will be available upon reasonable request as allowed by IRB regulations and after manuscripts reporting the main findings are accepted for publication. |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Analytic Code |
Time Frame: | Data will be available after manuscripts reporting the main findings are accepted for publication. |
Access Criteria: | Contact the principal investigator to request access to the deidentified data. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
multidisciplinary teamwork implementation |